Edwards Lifesciences Corporation (EW) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 1.65B | 1.57B | 1.55B | 1.53B | 1.41B | 1.39B | 1.35B | 1.39B | 1.33B | 1.27B | 1.24B | 1.3B |
| Revenue Growth % | 16.7% | 13.26% | 14.67% | 10.56% | 6.23% | 9.43% | 8.93% | 6.98% | -8.89% | -6.07% | -5.73% | -5.71% |
| Cost of Goods Sold | 359.3M | 340.6M | 345.2M | 342.6M | 301.6M | 292.2M | 262.9M | 297.8M | 289.3M | 251M | 272.2M | 270.8M |
| COGS % of Revenue | 21.79% | 21.7% | 22.23% | 22.36% | 21.35% | 21.09% | 19.41% | 21.49% | 21.75% | 19.82% | 21.89% | 20.9% |
| Gross Profit | 1.29B | 1.23B | 1.21B | 1.19B | 1.11B | 1.09B | 1.09B | 1.09B | 1.04B | 1.02B | 971.2M | 1.02B |
| Gross Margin % | 78.21% | 78.3% | 77.88% | 77.64% | 78.65% | 78.91% | 80.59% | 78.51% | 78.25% | 80.18% | 78.11% | 79.1% |
| Gross Profit Growth % | 16.04% | 12.38% | 10.82% | 9.33% | 6.77% | 7.7% | 12.39% | 6.19% | -5.43% | -3.54% | -6.44% | -5.84% |
| Operating Expenses | 774.6M | 858.7M | 784.5M | 758.7M | 716.3M | 781M | 740.9M | 723.4M | 685.1M | 658.7M | 624.7M | 654.1M |
| OpEx % of Revenue | 46.99% | 54.71% | 50.51% | 49.52% | 50.7% | 56.36% | 54.7% | 52.2% | 51.52% | 52.01% | 50.24% | 50.49% |
| Selling, General & Admin | 522.2M | 602.9M | 514.6M | 502M | 465.7M | 491.9M | 421.4M | 450.8M | 428.4M | 416.6M | 381.9M | 410.4M |
| SG&A % of Revenue | 31.68% | 38.41% | 33.13% | 32.76% | 32.97% | 35.5% | 31.11% | 32.53% | 32.21% | 32.9% | 30.71% | 31.68% |
| Research & Development | 263.3M | 267.7M | 280.7M | 276.2M | 254.6M | 271.1M | 253.4M | 272.6M | 256.7M | 242.1M | 242.8M | 243.7M |
| R&D % of Revenue | 15.97% | 17.06% | 18.07% | 18.03% | 18.02% | 19.56% | 18.71% | 19.67% | 19.3% | 19.12% | 19.53% | 18.81% |
| Other Operating Expenses | -1000K | -1000K | -1000K | -1000K | -1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 514.7M | 370.3M | 425.1M | 430.9M | 394.8M | 312.6M | 350.6M | 364.7M | 355.5M | 356.7M | 346.5M | 370.6M |
| Operating Margin % | 31.22% | 23.59% | 27.37% | 28.12% | 27.95% | 22.56% | 25.89% | 26.31% | 26.73% | 28.17% | 27.87% | 28.61% |
| Operating Income Growth % | 30.37% | 18.46% | 21.25% | 18.15% | 11.05% | -12.36% | 1.18% | -1.59% | -11.74% | -12.89% | -18.89% | -13.49% |
| EBITDA | 555.6M | 413M | 464.3M | 469M | 431.4M | 355.2M | 385.1M | 404.3M | 394M | 393.4M | 383.4M | 406.7M |
| EBITDA Margin % | 33.7% | 26.31% | 29.89% | 30.61% | 30.54% | 25.63% | 28.43% | 29.17% | 29.63% | 31.06% | 30.83% | 31.39% |
| EBITDA Growth % | 28.79% | 16.27% | 20.57% | 16% | 9.49% | -9.71% | 0.44% | -0.59% | -11.42% | -12.87% | -18.3% | -13.34% |
| D&A (Non-Cash Add-back) | 40.9M | 42.7M | 39.2M | 38.1M | 36.6M | 42.6M | 34.5M | 39.6M | 38.5M | 36.7M | 36.9M | 36.1M |
| EBIT | 459M | 90.4M | 348.4M | 362.1M | 433.9M | 441.1M | 394.3M | 386.6M | 371.2M | 367.2M | 387.6M | 275.1M |
| Net Interest Income | 33.5M | 35.9M | 38.6M | 37.4M | 19.5M | 44.2M | 23.5M | 16.5M | 19M | 16.8M | 16.3M | 12.9M |
| Interest Income | 33.5M | 35.9M | 38.6M | 37.4M | 19.5M | 44.2M | 23.5M | 16.5M | 19M | 16.8M | 16.3M | 12.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -55.7M | -279.9M | -76.7M | -30.7M | 39.1M | 77.5M | 52.2M | 21.9M | 15.7M | 10.5M | 41.1M | -95.5M |
| Pretax Income | 459M | 90.4M | 348.4M | 400.2M | 433.9M | 390.1M | 402.8M | 386.6M | 371.2M | 367.2M | 387.6M | 275.1M |
| Pretax Margin % | 27.84% | 5.76% | 22.43% | 26.12% | 30.71% | 28.15% | 29.74% | 27.9% | 27.91% | 29% | 31.17% | 21.23% |
| Income Tax | 78.3M | 26.2M | 56.1M | 64.3M | 70.3M | 45.1M | 40.7M | 20.2M | 46.3M | 34.1M | 52.7M | 20.9M |
| Effective Tax Rate % | 17.06% | 28.98% | 16.1% | 16.07% | 16.2% | 11.56% | 10.1% | 5.23% | 12.47% | 9.29% | 13.6% | 7.6% |
| Net Income | 380.7M | 91.2M | 291.1M | 329.8M | 358M | 385.6M | 3.07B | 363.7M | 351.9M | 369.9M | 384.9M | 307.1M |
| Net Margin % | 23.09% | 5.81% | 18.74% | 21.52% | 25.34% | 27.83% | 226.73% | 26.24% | 26.46% | 29.21% | 30.96% | 23.71% |
| Net Income Growth % | 6.34% | -76.35% | -90.52% | -9.32% | 1.73% | 4.24% | 697.82% | 18.43% | 3.35% | -7.15% | 12.05% | -24.43% |
| Net Income (Continuing) | 380.7M | 64.2M | 292.3M | 335.9M | 363.6M | 345M | 362.1M | 366.4M | 324.9M | 333.1M | 334.9M | 254.2M |
| Discontinued Operations | 0 | 1000K | -1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K |
| Minority Interest | 0 | 0 | 0 | 61.2M | 62.9M | 64.5M | 65.8M | 67.2M | 68.5M | 69.4M | 69.6M | 70.8M |
| EPS (Diluted) | 0.66 | 0.16 | 0.50 | 0.56 | 0.61 | 0.65 | 5.13 | 0.61 | 0.58 | 0.61 | 0.63 | 0.50 |
| EPS Growth % | 8.2% | -75.38% | -90.25% | -8.2% | 5.17% | 6.56% | 714.29% | 22% | 3.57% | -6.15% | 14.55% | -23.08% |
| EPS (Basic) | 0.66 | 0.16 | 0.50 | 0.57 | 0.61 | 0.65 | 5.14 | 0.61 | 0.58 | 0.61 | 0.63 | 0.51 |
| Diluted Shares Outstanding | 580.7M | 581.8M | 585.7M | 587.9M | 587.8M | 590.5M | 598.1M | 604.3M | 604.1M | 606.9M | 609.5M | 610.3M |
| Basic Shares Outstanding | 579.2M | 580.4M | 584.7M | 587M | 586.9M | 589.8M | 597.2M | 602.1M | 601.6M | 605.2M | 607M | 606.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |